A Multi-Center, Open-Label, Non-Comparative Study Investigating the Efficacy and Tolerability of Angeliq® in Postmenopausal Thai Women With Vasomotor Symptoms Over Three 28-Day Treatment Cycles
Sponsor study identifier
Secondary identifiers
interventional
55
0 countries
N/A
Study Start
September 2005
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
Not reported
Date not reportedStudy Completion
December 2006
Actual (reported)To evaluate the safety, tolerability, and efficacy of Angeliq in Thai post menopausal women with hot flushes and other climacteric symptoms.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
December 2006
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
September 2005
Date type not reportedThis date has not been verified as actual or estimated.
September 12, 2005
Actual (reported)September 16, 2005
Actual (reported)December 2006
Actual (reported)The relative change in the frequency of hot flushes
At baseline, week 4, 8, 12
The change in intensity of hot flushes
At baseline, week 4, 8, 12
The relative change in frequency of hot flushes
At baseline, week 4, 8
The change in intensity of hot flushes
At baseline, week 4, 8
The proportions of subjects with urogenital symptoms
At baseline, week 4, 8, 12
Bleeding pattern
At baseline, week 4, 8, 12
1 tablet of 2 mg drospirenone and 1 mg estradiol, orally administered once daily, over three 28-day treatment cycles
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Bayer Study Director
Bayer
55 participants (actual enrollment reported by the registry).
First Submitted
September 12, 2005
First Posted
September 16, 2005
Study Start
September 2005
Date type not reportedThis date has not been verified as actual or estimated.
Study Comparing Four New Formulations for Premarin in Healthy Postmenopausal Women
Contact the study team to confirm eligibility.
Study Completion
December 2006
Actual (reported)Last Updated
December 12, 2008
Record last verified: 2008-12
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: